<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Blockade of ␣4 Integrin Signaling Ameliorates the Metabolic Consequences of High-Fat Diet-Induced Obesity</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chloé</forename><forename type="middle">C</forename><surname>Fé Ral</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Diego, La Jolla</addrLine>
									<region>California</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institut National de la Santé et de la Recherche Mé dicale, U634, Nice</orgName>
								<orgName type="institution">Sophia Antipolis University</orgName>
								<address>
									<settlement>Nice</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaap</forename><forename type="middle">G</forename><surname>Neels</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Diego, La Jolla</addrLine>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christiane</forename><surname>Kummer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Diego, La Jolla</addrLine>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marina</forename><surname>Slepak</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Diego, La Jolla</addrLine>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jerrold</forename><forename type="middle">M</forename><surname>Olefsky</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Diego, La Jolla</addrLine>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">H</forename><surname>Ginsberg</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>San Diego, La Jolla</addrLine>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chloé</forename><forename type="middle">C</forename><surname>Fé</surname></persName>
						</author>
						<title level="a" type="main">Blockade of ␣4 Integrin Signaling Ameliorates the Metabolic Consequences of High-Fat Diet-Induced Obesity</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.2337/db07-1751.</idno>
					<note type="submission">Received 13 December 2007 and accepted 14 April 2008.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:00+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>OBJECTIVE-Many prevalent diseases of advanced societies, such as obesity-induced type 2 diabetes, are linked to indolent mononuclear cell-dependent inflammation. We previously proposed that blockade of ␣4 integrin signaling can inhibit inflammation while limiting mechanism-based toxicities of loss of ␣4 function. Thus, we hypothesized that mice bearing an ␣4(Y991A) mutation, which blocks signaling, would be protected from development of high-fat diet-induced insulin resistance. RESEARCH DESIGN AND METHODS-Six-to eight-weekold wild-type and ␣4(Y991A) C57Bl/6 male mice were placed on either a high-fat diet that derived 60% calories from lipids or a chow diet. Metabolic testing was performed after 16-22 weeks of diet. RESULTS-␣4(Y991A) mice were protected from development of high-fat diet-induced insulin resistance. This protection was conferred on wild-type mice by ␣4(Y991A) bone marrow transplantation. In the reverse experiment, wild-type bone marrow renders high-fat diet-fed ␣4(Y991A) acceptor animals insulin resistant. Furthermore, fat-fed ␣4(Y991A) mice showed a dramatic reduction of monocyte/macrophages in adipose tissue. This reduction was due to reduced monocyte/macrophage migration rather than reduced monocyte chemoattractant protein-1 production. CONCLUSIONS-␣4 integrins contribute to the development of HFD-induced insulin resistance by mediating the trafficking of monocytes into adipose tissue; hence, blockade of ␣4 integrin signaling can prevent the development of obesity-induced insulin resistance. Diabetes 57:1842-1851, 2008 RESEARCH DESIGN AND METHODS Animals and animal care. The ␣4(Y991A) mice were previously described and have been backcrossed nine times onto the C57BL/6 background (18). We fed male mice (aged 6-8 weeks) either on high-fat diet, containing 60% fat by weight (D12492; Research Diets) or on chow diet (10% fat; D12450B; Research Diets) for 16-22 weeks. All experiments were approved by the University of California San Diego Institutional Animal Care and Use Committee. Glucose and insulin tolerance tests. We carried out glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs) as described previously (19) (see From the</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>O</head><p>besity leads to insulin resistance that results in type 2 diabetes <ref type="bibr" target="#b0">(1)</ref> and that contributes to hypertension and cardiovascular disease <ref type="bibr" target="#b1">(2)</ref>. Mononuclear cell-mediated inflammation in obese adipose tissue plays a pathogenetic role in insulin resistance <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4)</ref>. Thus, there is great interest in the possibility of using anti-inflammatory strategies to ameliorate obesity-induced insulin resistance.</p><p>Blockade of leukocyte adhesion is a proven therapeutic strategy for a wide variety of inflammatory diseases <ref type="bibr" target="#b4">(5)</ref>. In particular, inhibiting ␣4 integrins or their counterreceptors (vascular cell adhesion molecule-1  and mucosal adressin cell adhesion molecule-1 [MadCAM-1]) blocks inflammatory responses mediated by mononuclear leukocytes <ref type="bibr" target="#b5">(6)</ref>. ␣4 integrin antagonists are of proven benefit in several human inflammatory diseases <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b7">8)</ref>. These antagonists, such as the monoclonal antibody natalizumab, block ligand binding function, thus producing a complete loss of ␣4 integrin function. Lack of ␣4 integrins is embryonic lethal and results in defective placentation, heart development, and hematopoiesis <ref type="bibr">(9 -11)</ref>. Furthermore, natalizumab therapy has been associated with fatal progressive multifocal leukoencephalopathy in humans, possibly because of defective T-cell trafficking to the brain <ref type="bibr" target="#b12">(12,</ref><ref type="bibr" target="#b13">13)</ref>. Thus, currently available ␣4 integrin antagonists are of proven value in mononuclear cell-mediated diseases; however, complete loss of ␣4 integrin function is associated with developmental defects and abnormal hematopoiesis.</p><p>As noted above, whereas ␣4 integrin antagonists show promise for several autoimmune and inflammatory diseases, mechanism-based toxicities may limit their use, particularly in low-grade chronic inflammatory conditions, such as obesity-induced insulin resistance. We recently proposed an alternative strategy-blockade of ␣4 integrin signaling-to perturb functions involved in inflammation, while limiting mechanism-based adverse effects <ref type="bibr" target="#b14">(14)</ref>. ␣4 integrin signaling involves the binding of paxillin to the ␣4 integrin tail, and a point mutation (␣4Y991A) that selectively blocks this interaction reduces ␣4-mediated leukocyte migration <ref type="bibr" target="#b15">(15)</ref> and adhesion strengthening in flowing blood <ref type="bibr" target="#b16">(16)</ref> while sparing ␣4-mediated static cell adhesion <ref type="bibr" target="#b17">(17)</ref>. Furthermore, mice bearing an ␣4(Y991A) mutation are viable and fertile and have intact lympho-hematopoiesis and humoral immune responses; however, they exhibit defective recruitment of mononuclear leukocytes in experimental inflammation <ref type="bibr" target="#b18">(18)</ref>. Here, we report that the ␣4(Y991A) mutation reduces mononuclear leukocyte infiltration of white adipose tissue (WAT) in high-fat dietinduced obese mice and hence reduce high-fat dietinduced insulin resistance. Thus, we establish that blocking ␣4 integrin signaling can ameliorate the metabolic consequences of high-fat diet-induced obesity.</p><p>supplemental methods in the online appendix available at http://dx.doi.org/ 10.2337/db07-1751). Whole-blood and plasma measurements. Total white blood cell number and differential counts were assessed by standard techniques (ACP Diagnostic Lab, University of California, San Diego). We measured plasma insulin by radioimmunoassay (Linco Research) and determined free fatty acids by colorimetric assay (Wako). Plasma cytokines were measured by the core laboratories of the Diabetes and Endocrinology Research Consortium (University of California, Los Angeles; LINCOplex assay for Mouse Cytokines, http://www.derc.med.ucla.edu/core.htm). Plasma cholesterol and triglyceride levels were measured by enzymatic methods using an automated bichromatic analyzer (Abbot Diagnostics). All of these measurements were performed on 11 wild-type and 9 ␣4(Y991A) mice for high-fat diet and 6 wild-type and 5 ␣4(Y991A) mice for chow diet <ref type="table" target="#tab_0">(Table 1)</ref>. Histochemistry. Adipose tissue was fixed overnight in 10% formaldehyde, dehydrated in ethanol bath, and paraffin-embedded. Sections were stained with hematoxylin-eosin (H-E) for observation of adipose tissue structure. Pancreas isolation and determination of islet area. Pancreata were isolated and fixed in 4% formalin overnight. Paraffin sections were generated and stained with H-E. Pictures were taken of H-E-stained pancreas sections, and the area of Langerhans islets and the total area of the pancreas were measured using ImageJ software (NIH freeware). Islet area was depicted as percentage of total pancreas area. Sections of four to seven mice per group and at least six different pancreas areas per mouse were analyzed for statistical significance using unpaired two-tailed Student's t test. P values Ͻ0.05 were considered significant. Bone marrow transplantation. We injected bone marrow obtained from wild-type and ␣4(Y991A) mice (4 ϫ 10 6 cells) through the tail vein into male C57BL/6 (4 months) and ␣4(Y991A) (4 -6 months) mice that had been irradiated (10 Gy) 4 h before. Mice were allowed 4 weeks for reconstitution of donor marrow, which we verified by PCR <ref type="bibr" target="#b18">(18)</ref>. Isolation of stromal vascular cells. Epidydimal fat pads were minced in PBS and digested with collagenase (Roche) and DNase I (Sigma) for 1 h at 37°C. Suspensions were then filtered through a 100-m nylon cell strainer and then spun at 1,000g for 10 min. The preadipocyte/adipocyte-enriched fraction was removed. Isolated stromal vascular cells were resuspended in red blood cell lysis buffer (10 mmol/l KHCO 3 , 150 mmol/l NH 4 Cl, and 0.1 mmol/l EDTA, pH 8) for 5 min at room temperature. Cell suspension was centrifuged for 5 min at 500g, and stromal vascular cells were resuspended in PBS at 10 6 cells/100 l. Flow cytometry. Cells were harvested from WAT, peripheral blood, and bone marrow and incubated in Fc blocker (rat anti-mouse CD16/32) for 20 min at room temperature. The cells were then incubated with fluorescein isothiocyanate (FITC)-Ly-6G (1/200) and phycoerythrin (PE)-7/4 (1/50) (BD Biosciences/ PharMingen, San Diego, CA). Negative control staining was performed with FITC-rat IgG2a/k and PE-rat IgG2a. Cell staining was analyzed with FACScan flow cytometer using CellQuest software (BD Biosciences Systems). Cell migration assay. Cell migration was assayed in a modified Boyden chamber system using a 24-well transwell plate (8-m pore size; Corning) coated with 5 g/ml VCAM-1 (R&amp;D Systems). Monocyte chemoattractant protein-1 (MCP-1) (R&amp;D Systems) was added in the lower chamber at 1 nmol/l. Cells harvested from wild-type or ␣4(Y991A) bone marrow were grown for 5-7 days in the presence of granulocyte macrophage-colonystimulating factor (5 l of 0.1 mg/ml stock solution). Bone marrow-derived macrophages (2 ϫ 10 4 ) were kept in suspension in 1% serum containing medium for 1 h at room temperature. Cells were then added to the top chamber and incubated overnight at 37°C. Filters were fixed and stained with crystal violet, and migrated cells in the lower chamber were enumerated. RNA isolation and RT-PCR. Total RNA was isolated from WAT using RNeasy Lipid Tissue kit (Qiagen). RT-PCRs were carried out as described in the online appendix <ref type="bibr" target="#b20">(20)</ref>. Statistical analysis. Means and SEs were calculated for all dependent measures. Data were analyzed for statistical significance using the one-or two-tailed Student's t test. Significance was set at P Յ 0.05. For <ref type="figure" target="#fig_0">Fig. 1B</ref>, change scores for the chow diet and high-fat diet data were determined using the total area under the curve (AUC) <ref type="bibr" target="#b21">(21)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>␣4(Y991A) mutation is protective against the development of high-fat diet-induced glucose intolerance and insulin resistance. To investigate the role(s) of integrin ␣4 interaction with paxillin in ␣4-mediated functions in vivo, we previously generated and analyzed mice bearing a point mutation in the ␣4 integrin tail (Y991A) that inhibits paxillin binding with little detectable effect on the binding of other proteins <ref type="bibr" target="#b18">(18)</ref>. To examine the potential effect of this mutation on a model of human type 2 diabetes, these ␣4(Y991A) mice and wild-type controls were placed on a 60% fat diet for 16 -22 weeks. On this diet, wild-type animals developed impaired glucose tolerance <ref type="figure" target="#fig_0">(Fig. 1A)</ref>. In contrast, mice bearing the ␣4(Y991A) mutation were partially protected against high-fat diet-induced glucose intolerance ( <ref type="figure" target="#fig_0">Fig. 1A; Supplemental Fig. 1A</ref>). The increased glucose tolerance in the high-fat diet-fed ␣4(Y991A) animals was not due to greater insulin release because these mice released significantly less insulin than high-fat dietfed wild-type animals (P ϭ 0.036) <ref type="figure" target="#fig_0">(Fig. 1B.)</ref>. The wild-type mice showed a greater increase in pancreatic ␤-cells than those bearing the ␣4(Y991A) mutation <ref type="figure" target="#fig_0">(Fig. 1C</ref>) in response to the high-fat diet. Because increased ␤-cells is an early manifestation of insulin resistance (22), these findings strongly suggested that the ␣4(Y991A) mutation helped preserve sensitivity to insulin in fat-fed animals. This idea was confirmed by the finding that the high-fat diet-fed mutant mice showed a much greater insulininduced drop in blood glucose than the high-fat diet-fed wild-type mice <ref type="figure" target="#fig_0">(Fig. 1D</ref>). Thirty minutes after administration of 0.85 units/kg insulin, plasma glucose decreased by 43% in the mutant fat-fed animals compared with a 28% decline in wild-type animals. In contrast, the chow-fed animals of both genotypes exhibited a 37% decline at 30 min (0.75 units/kg insulin injected). At later time points, there was a statistically insignificant trend of greater insulin-induced drop in chow-fed ␣4(Y991A) animals ver-  sus wild type. Thus, the ␣4(Y991A) mutation protects against high-fat diet-induced insulin resistance. The ␣4(Y991A) mutation did not affect caloric intake or weight gain. Both wild-type and ␣4(Y991A) mice exhibited the same caloric intake on high-fat diet ( <ref type="figure" target="#fig_1">Fig. 2A</ref>, left), which was about 1.5-fold higher than on chow diet ( <ref type="figure" target="#fig_1">Fig. 2A, right)</ref>. Consistent with similar caloric intake, no differences in weight gain were observed between wildtype and ␣4(Y991A) mice <ref type="figure" target="#fig_1">(Fig. 2B, left and right)</ref>. Animals were weight matched before starting the 16 weeks of diet [average starting weight for high-fat diet, 27.8 Ϯ 0.6 and 27.3 Ϯ 1.0 g for wild type and ␣4(Y991A), respectively; for chow diet, 27.8 Ϯ 1.3 and 28.8 Ϯ 1.6 g for wild type and ␣4(Y991A), respectively]). Gross histological analysis of WAT isolated from high-fat diet-fed wild-type and ␣4(Y991A) mice showed no statistical difference in adipocyte size or number ( <ref type="figure" target="#fig_1">Fig. 2C</ref>; Supplemental <ref type="figure" target="#fig_0">Fig. 1B</ref>). Plasma levels of free fatty acids and triglycerides were similar between wild-type and ␣4(Y991A) mice on both diets <ref type="table" target="#tab_0">(Table 1)</ref>. Wild-type mice exhibited increased plasma cholesterol on high-fat diet (238.7 Ϯ 10.5 mg/dl) in comparison with those on chow diet (132.2 Ϯ 5.9 mg/dl). The ␣4(Y991A) mice on high-fat diet exhibited a statistically insignificant trend to a lesser rise in cholesterol (203.0 Ϯ 27.9 vs. 130.0 Ϯ 2.7 mg/dl, high-fat diet vs. chow diet), which may reflect a decrease in LDL levels. Plasma adiponectin concentrations decreased to similar levels in both high-fat-fed wild-type and ␣4(Y991A) mice. Plasma leptin and resistin levels increased after high-fat diet, but no differences were found between genotypes <ref type="table" target="#tab_0">(Table 1)</ref>. High-fat diet-fed ␣4(Y991A) mice exhibited similar plasma expression of proinflammatory cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-␣ (TNF-␣), and MCP-1, compared with wild-type mice <ref type="table" target="#tab_0">(Table 1)</ref>. Bone marrow-derived cells are responsible for protection from high-fat diet-induced insulin resistance. Even though ␣4 integrin is not present at the surface of adipocytes (data not shown), it is widely expressed <ref type="bibr" target="#b24">(23,</ref><ref type="bibr" target="#b25">24)</ref> and is particularly prominent in the functioning of mononuclear leukocytes. Moreover, bone marrow-derived mononuclear cells contribute to insulin resistance <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b26">25)</ref>. To determine whether the protection against high-fat diet-induced insulin resistance in the ␣4(Y991A) mice is mediated through bone marrow-derived cells, we performed bone marrow transplantation (BMT) experiments. Six-to eight-week-old lethally irradiated (10 Gy) wild-type male mice received bone marrow cells from either wildtype or ␣4(Y991A) donor mice via tail vein injection. Recipient mice were allowed 4 weeks for recovery and reconstitution of the transplanted bone marrow and were then placed on high-fat diet for 16 -22 weeks before metabolic experiments. Posttransplant chimerism was evaluated by PCR on both groups. No wild-type ␣4 was detected in blood collected from mice receiving bone marrow from ␣4(Y991A) mice [␣4(Y991A)-BMT]. Mice transplanted with wild-type and ␣4 mutant [␣4(Y991A)-BMT] bone marrow gained equal amounts of weight on high-fat diet compared with normal chow (data not shown). Levels of plasma fatty acids, cholesterol, triglycerides, adiponectin, and leptin were similar between genotypes (data not shown).</p><p>Wild-type mice that received ␣4(Y991A) bone marrow were partially protected against high-fat diet-induced glucose intolerance <ref type="figure" target="#fig_2">(Fig. 3A</ref>) and insulin resistance <ref type="figure" target="#fig_2">(Fig. 3B)</ref> compared with wild-type animals that received wild-type bone marrow. When animals were fed a normal diet, glucose tolerance was similar in mutant and wild-type transplanted mice <ref type="figure" target="#fig_2">(Fig. 3A)</ref>, but there was a statistically insignificant trend toward increased insulin sensitivity in chow-fed ␣4(Y991A) compared with wild-type marrow recipients <ref type="figure" target="#fig_2">(Fig. 3C)</ref>. In reverse BMT experiments, i.e., transplantation of wild-type bone marrow into lethally irradiated ␣4(Y991A) mice, no mutant allele was detected in ␣4(Y991A) animals receiving wild-type bone marrow, confirming complete reconstitution of wild-type bone marrow in these animals. Wild-type marrow made ␣4(Y991A) acceptor mice susceptible to glucose intolerance (Supplemental <ref type="figure" target="#fig_1">Fig. 2)</ref>. Thus, bone marrow-derived cells are responsible for the observed protection of ␣4(Y991A) mice from high-fat diet-induced insulin resistance. The ␣4(Y991A) mutation leads to a decrease in adipose tissue monocyte/macrophages in high-fat dietfed mice. The foregoing experiments showed that the effect of the ␣4(Y991A) mutation was manifest through bone marrow-derived cells. Among bone marrow-derived cells, ␣4 integrin is highly expressed on most mononuclear leukocytes <ref type="bibr" target="#b27">(26)</ref>. Monocyte/macrophages are bone marrowderived mononuclear cells that mediate the inflammatory response to high-fat diet, and macrophages contribute to the pathogenesis of obesity-induced insulin resistance <ref type="bibr" target="#b26">(25,</ref><ref type="bibr" target="#b28">27)</ref>. We therefore used flow cytometry to quantify the presence of monocyte subpopulations, defined by the level of expression of surface markers 7/4 and Ly6-G (28) in the stromal vascular fraction (SVF) of WAT isolated from wild-type and ␣4(Y991A) mice on chow or high-fat diet. We used a combination of Ly-6G and 7/4 markers, described by Tsou et al. <ref type="bibr" target="#b29">(28)</ref>, which define a cell population uniformly positive for F4/80, CD11b, and CC chemokine receptor 2 for CCL2/MCP-1 (CCR2) and phenotypically identical to the inflammatory monocytes previously described <ref type="bibr">(29 -32)</ref>.</p><p>The accumulation of macrophages, associated with obesity-induced insulin resistance, occurs predominantly in epididymal WAT (25,33); hence we studied WAT from this site. High-fat diet-fed ␣4(Y991A) mice exhibited a marked reduction in the number of monocytes (7/4 hi Ly-6G neg ) compared with high-fat diet-fed wild-type mice (0.8 Ϯ 0.13 vs. 2.88 Ϯ 0.49%) <ref type="figure">(Fig. 4A</ref>, top left panel) in WAT SVF. This phenomenon was also observed <ref type="figure">(Fig. 4A</ref>, bottom left panel) with 7/4 dim Ly-6G neg cells (mixed monocyte/lymphocytes) (Y991A 3.77 Ϯ 1.43% vs. wild type 7.6 Ϯ 1.11%). In contrast, when fed a normal diet, wild-type and ␣4(Y991A) mice had similar percentages of both 7/4 hi Ly-6G neg and 7/4 dim Ly-6G neg cells in their WAT SVF <ref type="figure">(Fig. 4A, right  panels)</ref>. These results were confirmed by the reduction in mRNA for F4/80, a macrophage marker, in WAT from fat-fed ␣4(Y991A) mice compared with wild-type mice (Supplemental <ref type="figure" target="#fig_0">Fig. 1C)</ref>. Thus, the ␣4(Y991A) mutation leads to a reduction in monocyte/macrophage accumulation in the WAT SVF in response to high-fat diet.</p><p>WAT monocyte/macrophages derive in part from peripheral blood monocytes, which in turn are derived from the bone marrow. To investigate the cause of the reduced monocyte/macrophage accumulation in WAT of ␣4(Y991A) mice, we quantified monocyte subpopulations in the peripheral blood and in the bone marrow of wild-type and ␣4(Y991A) mice. In the high-fat diet-fed mice, there was a reduction in the percentage (1.4 Ϯ 0.28 vs. 2.9 Ϯ 0.38% for Y991A and wild type, respectively) and absolute number of monocytes in the peripheral blood of ␣4(Y991A) mice <ref type="figure">(Fig. 4A and B)</ref>. In contrast, there was no significant difference in the percentage of pure or mixed monocyte populations in the bone marrow of high-fat diet-fed wild-type and ␣4(Y991A) mice <ref type="figure">(Fig. 4A)</ref>. Similarly, a slight monocytopenia was observed in the peripheral blood of normal chow-fed ␣4(Y991A) mice (1.71 Ϯ 0.13 vs. 2.39 Ϯ 0.12% for Y991A and wild type, respectively), and there was no significant difference in abundance of 7/4 hi Ly-6G neg and 7/4 dim Ly-6G neg cells in the bone marrow <ref type="figure">(Fig. 4)</ref>. Taken together, these data suggest that the ␣4(Y991A) mutation does not impair monocyte development. Rather, they suggest that the mutation reduces mobilization of these cells. These data do not define the relative contributions of reduced egress from the bone marrow and entry into the adipose tissue in high-fat diet-fed mice in the observed reduced macrophage accumulation in ␣4(Y991A) WAT. ␣4(Y991A) monocyte/macrophages exhibit reduced chemotaxis toward MCP-1. MCP-1 is an important monocyte chemoattractant and is particularly implicated in the mobilization of monocytes from the bone marrow and the infiltration of adipose tissue with monocyte/ macrophages <ref type="bibr" target="#b35">(34,</ref><ref type="bibr" target="#b36">35)</ref>. Thus, we hypothesized that the decreased 7/4 hi Ly-6G neg and 7/4 dim Ly-6G neg cells in WAT of high-fat diet-fed ␣4(Y991A) mice could be due to impaired migration in response to this chemokine. ␣4(Y991A) bone marrow-derived macrophages showed reduced ␣4 integrin-dependent MCP-1-driven migration relative to wildtype cells <ref type="figure">(Fig. 5A)</ref>. Thus, impaired ␣4 integrin-dependent monocyte/macrophage migration can account for the decreased number of monocyte/macrophages detected in WAT of fat-fed ␣4(Y991A) mice. Chemokines, such as MCP-1, are produced by macrophages, endothelial cells, and adipocytes <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b37">36,</ref><ref type="bibr" target="#b38">37)</ref>. Deficiency in MCP-1 production and/or secretion could also contribute to an impairment of monocyte/macrophages migration into adipose tissue (4). Circulating MCP-1 was increased approximately twofold after highfat diet, but no significant difference was observed between genotypes ( <ref type="table" target="#tab_0">Table 1</ref>). The relative expression of MCP-1 was also evaluated in the WAT of ␣4(Y991A) and wild-type mice by RT-PCR <ref type="figure">(Fig. 5B)</ref>. As expected from the circulating level of MCP-1, no difference was observed in MCP-1 mRNA expression in epididymal WAT between genotype in high-fat diet-fed mice <ref type="figure">(Fig. 5B)</ref>. Thus, we ascribe the reduction in monocyte/macrophages in WAT in high-fat diet-fed mice to an impaired migratory response to MCP-1 rather than to reduced production of this chemokine.</p><p>The amelioration of insulin resistance in high-fat dietfed ␣4(Y991A) mice appears to depend on reduction of monocyte/macrophages in WAT; these cells are the source of cytokines, such as TNF-␣ and IL-6. Abdominal adipose gene expression levels of TNF-␣, IL-6, plasminogen activator inhibitor 1 (PAI-1), and leptin are positively linked with insulin resistance. Levels of proinflammatory cytokines TNF-␣ and IL6 were strikingly reduced (70 and 55%, respectively) in ␣4(Y991A) compared with wild-type WAT <ref type="figure">(Fig. 5C</ref>). In contrast, we observed similar levels for fat-derived peptides leptin and PAI-1 in wild-type and ␣4(Y991A) WAT. Thus, the reduction in monocyte/macrophages in WAT in high-fat diet-fed ␣4(Y991A) mice leads to reduced production of pro-inflammatory cytokines (TNF-␣ and IL-6) in WAT.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>␣4 integrins are proven therapeutic targets in chronic inflammatory diseases, such as multiple sclerosis; however, complete blockade of ␣4 integrin function can result in defects in hematopoiesis, heart, and placental development <ref type="bibr" target="#b8">(9,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b39">38,</ref><ref type="bibr" target="#b40">39)</ref> and is associated with progressive multifocal leukoencephalopathy <ref type="bibr" target="#b13">(13)</ref>. Chronic low-grade inflammation contributes to the development of insulin resistance <ref type="bibr" target="#b41">(40)</ref>, and the adipose tissue macrophage is a principal cell type responsible <ref type="bibr" target="#b28">(27)</ref>. Here, we report that mice bearing the ␣4(Y991A) mutation are protected from high-fat diet-induced glucose intolerance and insulin resistance. The mutation did not block development of monocytes in the bone marrow but impaired their migration in response to MCP-1, leading to a combination of reduced egress into the blood and diminished accumulation in adipose tissue. Reduction of ␣4(Y991A) monocyte/macrophages in WAT consequently diminished proinflammatory cytokine (IL-6 and TNF-␣) production, which can explain the amelioration of insulin resistance in these mice. This is the first study showing a role for integrin signaling in the pathogenesis the metabolic consequences of diet-induced obesity. ␣4 integrins are important in the pathogenesis of highfat diet-induced insulin resistance because they mediate the localization of monocyte/macrophages to adipose tissue. In particular, we found that a point mutation that impairs ␣4 integrin signaling led to markedly improved glucose tolerance and insulin sensitivity in high-fat dietfed mice. The ␣4(Y991A) mice become obese on a high-fat diet, but they remained insulin-sensitive. This insulinsensitive phenotype can be conferred by transplanting bone marrow from ␣4(Y991A) mice into irradiated wildtype host animals. In the reverse experiment, fat-fed ␣4(Y991A) mice receiving wild-type bone marrow were insulin resistant. Thus, bone marrow-derived cells are responsible for this protective effect, most likely by limiting accumulation of inflammatory adipose tissue macrophages. Recent studies have begun to classify macrophage subpopulations with differing roles in insulin resistance; future studies will be required to define effects of the ␣4(Y991A) mutation on these subpopulations <ref type="bibr" target="#b42">(41)</ref><ref type="bibr" target="#b43">(42)</ref><ref type="bibr" target="#b44">(43)</ref><ref type="bibr" target="#b45">(44)</ref>. It is noteworthy that improvement of glucose tolerance in mutant mice fed a high-fat diet is not complete. This implies that other factors could contribute to glucose intolerance induced by high-fat diet. These results add insulin resistance/type 2 diabetes to diseases in which ␣4 integrins may serve as therapeutic targets.</p><p>Consistent with our results, MCP-1 deficiency or deletion of the MCP-1 receptor (CCR2) reduced monocyte egress from the bone marrow <ref type="bibr" target="#b29">(28)</ref> and accumulation of macrophages in adipose tissue (4), and MCP-1 or CCR2 KO mice are partially protected from high-fat diet-induced insulin resistance <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b46">45)</ref>. Thus, deletion of CCR2 or its main ligand leads to a similar phenotype as shown here for the ␣4(Y991A) mice. Furthermore, we demonstrated a defect in CCR2-driven chemotaxis in ␣4(Y991A) monocytes. These relationships suggest that CCR2-mediated monocyte recruitment is linked to the binding of paxillin to the ␣4 integrin cytoplasmic domain.</p><p>The phenotypes observed in the ␣4(Y991A) and ␣4(Y991A)-BMT animals are remarkably similar to those observed in mice deficient in Sorbs1 gene, which encodes cbl-associated protein (Cap) <ref type="bibr" target="#b19">(19)</ref>. These mice are also protected from high-fat diet-induced insulin resistance, and this protection can be transferred to wild-type mice by BMT of Cap-null bone marrow. Furthermore, Cap deletion resulted in reduced numbers of monocytes/macrophages in both blood and adipose tissue, and Cap knockdown led to decreased migration in the RAW264.7 macrophage cell line. Previously, Cap was shown to mediate signals for the formation of stress fibers and focal adhesions through interaction with the focal adhesion kinase p125 FAK , an effector directly linked to paxillin binding to ␣4 integrin <ref type="bibr" target="#b15">(15)</ref>, and Cbl is required for macrophage spreading and migration. Thus, the relationship between Cap and ␣4paxillin interaction in the pathogenesis of insulin resistance is an area of potential future interest.</p><p>Chronic inflammation can be a primary mediator of obesity-induced insulin resistance, and inflammation is recognized as one of the contributors to the metabolic syndrome (or syndrome X) and type 2 diabetes <ref type="bibr" target="#b47">(46)</ref>. This study establishes a new role for ␣4 signaling in the development of high-fat diet-induced insulin resistance through its action on monocyte/macrophage trafficking. It also suggests that blockade of ␣4 signaling can improve insulin sensitivity and reduce inflammation, which could translate into clinical benefit in type 2 diabetes. ACKNOWLEDGMENTS C.C.F. has received a postdoctoral fellowship from the Arthritis Foundation. J.G.N. has received Scientist Development Grant 0635408N from the American Heart Association. C.K. has received a postdoctoral fellowship from the Arthritis Foundation. J.M.O. has received a University of California Discovery Biostar Grant and NIH Grants DK-033651 and DK-074868. M.H.G. has received National Institutes of Health (NIH) Grants AR-27214, HL-078784, and HL-31950.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIG. 1 .</head><label>1</label><figDesc>␣4(Y991A) mutation protects mice against the development of high-fat diet-induced glucose intolerance and insulin resistance. A: In vivo glucose homeostasis was assessed by GTT in wild-type (ⅷ) and ␣4(Y991A) mice (□) on high-fat diet (plain symbols) and normal chow (dotted symbols). The results shown are means ؎ SE for each time point. B: Plasma insulin concentrations during GTT were collected. They are represented as total AUC, which was calculated using the trapezoidal method (see RESEARCH DESIGN AND METHODS for details). C: Size of pancreatic ␤-cell islets (right) in wild-type (closed) and ␣4(Y991A) (open) mice was measured. Representative H-E staining of wild-type and ␣4(Y991A) pancreas is also shown (left). Arrowheads indicate pancreatic islets. D: ITT was performed in wild-type (ⅷ) and ␣4(Y991A) mice (□) on high-fat diet (HFD; left) and normal chow (Chow; right). Plasma glucose was significantly higher in wild-type mice fed high-fat diet than in all other groups during both the GTTs and ITTs. No significant differences in plasma insulin during the GTT were found between the wild-type and ␣4(Y991A) mice on chow diet. Plasma insulin and percentage of pancreatic ␤-cell islets were significantly higher in the wild-type mice after high-fat diet. n values per group are indicated. *P &lt; 0.05; **P &lt; 0.01; ns, not significant.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIG. 2 .</head><label>2</label><figDesc>Normal caloric intake, weight gain, and adipocyte size in ␣4(Y991A) mice compared with wild-type mice after high-fat diet. Calorie intake (A) and weight gain (B) were measured in wild type (ࠗ) and ␣4(Y991A) (f) mice on high-fat diet (HFD; left) and normal chow (chow; right). C: H-E staining of WAT isolated from wild type (WT) and ␣4(Y991A) (YA) mice was performed. No significant difference was observed between genotypes within diet. n values are indicated.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIG. 3 .</head><label>3</label><figDesc>Bone marrow cells from ␣4(Y991A) mice are sufficient for protection against high-fat diet-induced insulin resistance. GTTs (A) and ITTs (B and C) were performed in wild-type mice that received bone marrow from either wild-type (ⅷ) or ␣4(Y991A) (□) donors. Recipient animals were on high-fat diet (HFD; plain symbols) or normal chow (Chow; dotted symbols). The results shown are means ؎ SE for each time point. Plasma glucose was significantly lower in high-fat diet-fed wild-type mice that received ␣4(Y991A) bone marrow than in all other groups during both the GTTs and ITTs. n values per group are indicated. *P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; ns, not significant.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG. 4 .FIG. 5 .</head><label>45</label><figDesc>High-fat diet-fed ␣4(Y991A) mice exhibit a decreased number of adipose tissue and peripheral blood monocyte/macrophages. A: Stromal vascular cells of WAT, peripheral blood (blood) cells, and bone marrow (BM) cells were isolated from wild-type (f) and ␣4(Y991A) (□) mice were stained for 7/4 and Ly-6G surface markers. Mice were fed with either high-fat diet (left) or normal chow (right). Quantification of 7/4 hi Ly-6G neg (pure monocytes; top) and 7/4 dim Ly-6G neg (mixed leukocyte population; bottom) cells was performed by flow cytometry. WAT of high-fat diet-fed ␣4(Y991A) mice contain a decreased number of pure monocyte (7/4 hi Ly-6G neg ) cells compared with wild type. The mixed population (7/4 dim Ly-6G neg ) also shows a decrease in the high-fat diet-fed ␣4(Y991A) WAT, although it does not reach significance. A slight monocytopenia (7/4 hi Ly-6G neg ) was measured in normal chow-fed ␣4(Y991A) mice, which was aggravated upon high-fat diet feeding. The decreased 7/4 dim Ly-6G neg cell number was observed only in peripheral blood of high-fat diet-fed ␣4 mutant mice. No significant differences were observed in monocyte/macrophage numbers in the bone marrow in the two genotypes regardless of diet. Values are means ؎ SE. B: Quantification of monocytes from wild-type (f) and ␣4(Y991A) (□) hemograms is shown. Cell morphology was used to identify monocytes. Note that ␣4(Y991A) monocytopenia worsen when mice are fed a high-fat diet. Values are means ؎ SE. n values per group are indicated. *P &lt; 0.05; **P &lt; 0.01; ns, not significant. ␣4(Y991A) monocyte/macrophages show reduced migration in vitro in response to stimulation with MCP-1. A: Bone marrow-derived macrophages isolated from wild-type and ␣4(Y991A) mice were added to the top chamber of a VCAM-1-coated transwell. Chemoattractant, MCP-1 (1 nmol/l), was added in the lower chamber. Cells were allowed to migrate for 16 h. After fixation, cells were stained with crystal violet, and the total number of migrated cells (bottom chamber) was enumerated. B: Levels of MCP-1 mRNA were determined in vivo in epididymal WAT from wild-type and ␣4(Y991A) mice by using real-time RT-PCR. The data were normalized to the expression of V-ATPase. No significant difference was seen between genotypes. C: Levels of IL-6, PAI-1, TNF-␣, and leptin mRNA were evaluated in vivo in WAT from wild-type and ␣4(Y991A) mice by real-time RT-PCR. Both TNF-␣ and IL-6 levels are decreased in ␣4(Y991A) compared with wild-type. Values are means ؎ SE (n ‫؍‬ 14). **P &lt; 0.01; ns, not significant.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1</head><label>1</label><figDesc>Plasma measurements of lipids and adipokines in wild-type and ␣4(Y991A) mice Plasma free fatty acids (mol ⅐ l Ϫ1 ⅐ ml Ϫ1 ) 0.71 Ϯ 0.23 0.44 Ϯ 0.07 0.89 Ϯ 0.15 0.61 Ϯ 0.09</figDesc><table><row><cell>Normal chow diet</cell><cell>High-fat diet</cell></row></table><note>Data are means Ϯ SE. n values per group are indicated. *Significant difference between diet within genotype. None of these parameters were statistically different between genotypes.</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">DIABETES, VOL. 57, JULY 2008</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Evolution from obesity to diabetes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Golay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Felber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabete Metab</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="3" to="14" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Effect of Insulin Resistance, Dyslipidemia, and Intra-abdominal Adiposity on the Development of Cardiovascular Disease and Diabetes Mellitus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><forename type="middle">J</forename><surname>Rader</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjmed.2007.01.003</idno>
		<idno type="PMID">17320517</idno>
	</analytic>
	<monogr>
		<title level="j">The American Journal of Medicine</title>
		<title level="j" type="abbrev">The American Journal of Medicine</title>
		<idno type="ISSN">0002-9343</idno>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="S12" to="S18" />
			<date type="published" when="2007-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">IKK-β links inflammation to obesity-induced insulin resistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Melek</forename><forename type="middle">C</forename><surname>Arkan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrea</forename><forename type="middle">L</forename><surname>Hevener</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Florian</forename><forename type="middle">R</forename><surname>Greten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shin</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhi-Wei</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">M</forename><surname>Long</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><surname>Wynshaw-Boris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giuseppe</forename><surname>Poli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jerrold</forename><surname>Olefsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Karin</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm1185</idno>
		<idno type="PMID">15685170</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<title level="j" type="abbrev">Nat Med</title>
		<idno type="ISSN">1078-8956</idno>
		<idno type="ISSNe">1546-170X</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="191" to="198" />
			<date type="published" when="2005-01-30" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kanda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Tateya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Tamori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kotani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Hiasa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Kitazawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kitazawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Miyachi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Egashira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kasuga</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci26498</idno>
		<idno type="PMID">16691291</idno>
		<idno type="PMCID">PMC1459069</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/26498/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">Journal of Clinical Investigation</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1494" to="1505" />
			<date type="published" when="2006-06-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Therapeutic Strategies in Autoimmune Diseases by Interfering with Leukocyte Endothelium Interaction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joachim</forename><surname>Rychly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barbara</forename><surname>Nebe</surname></persName>
		</author>
		<idno type="DOI">10.2174/138161206778559696</idno>
		<idno type="PMID">17073678</idno>
	</analytic>
	<monogr>
		<title level="j">Current Pharmaceutical Design</title>
		<title level="j" type="abbrev">CPD</title>
		<idno type="ISSN">1381-6128</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">29</biblScope>
			<biblScope unit="page" from="3799" to="3806" />
			<date type="published" when="2006-10-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Therapeutic targeting of molecules involved in leukocyte?endothelial cell interactions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicole</forename><forename type="middle">C</forename><surname>Kaneider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">J</forename><surname>Leger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Athan</forename><surname>Kuliopulos</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1742-4658.2006.05441.x</idno>
		<idno type="PMID">16956369</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Journal</title>
		<title level="j" type="abbrev">FEBS Journal</title>
		<idno type="ISSN">1742-464X</idno>
		<idno type="ISSNe">1742-4658</idno>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="4416" to="4424" />
			<date type="published" when="2006-10" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Natalizumab for Active Crohn&apos;s Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Subrata</forename><surname>Ghosh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eran</forename><surname>Goldin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fiona</forename><forename type="middle">H</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helmut</forename><forename type="middle">A</forename><surname>Malchow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jørgen</forename><surname>Rask-Madsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Rutgeerts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Petr</forename><surname>Vyhnálek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zdena</forename><surname>Zádorová</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tanya</forename><surname>Palmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><surname>Donoghue</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa020732</idno>
		<idno type="PMID">12510039</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="24" to="32" />
			<date type="published" when="2003-01-02" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Omar</forename><forename type="middle">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">A</forename><surname>Sheremata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lance</forename><forename type="middle">D</forename><surname>Blumhardt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">P A</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michele</forename><forename type="middle">A</forename><surname>Libonati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allison</forename><forename type="middle">J</forename><surname>Willmer-Hulme</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catherine</forename><forename type="middle">M</forename><surname>Dalton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">A</forename><surname>Miszkiel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><forename type="middle">W</forename><surname>O'connor</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa020696</idno>
		<idno type="PMID">12510038</idno>
		<ptr type="open-access" target="http://discovery.ucl.ac.uk/7676/1/7676.pdf" />
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="15" to="23" />
			<date type="published" when="2003-01-02" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Differential Requirements for α4 Integrins during Fetal and Adult Hematopoiesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alicia</forename><forename type="middle">G</forename><surname>Arroyo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joy</forename><forename type="middle">T</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><surname>Rayburn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">O</forename><surname>Hynes</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0092-8674(00)81301-x</idno>
		<idno type="PMID">8674127</idno>
		<idno type="PII">S0092-8674(00)81301-X</idno>
		<idno type="ark">ark:/67375/6H6-PW7JXMLP-H</idno>
		<idno type="istexId">754CBA01EDF97CA12BF55BA47739412A4A946320</idno>
		<ptr type="open-access" target="http://web.mit.edu/ccrhq/hyneslab/2nd floor/Website PDFS/Differential Requirements.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<title level="j" type="abbrev">Cell</title>
		<idno type="ISSN">0092-8674</idno>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="997" to="1008" />
			<date type="published" when="1996-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Dual functions of [alpha]4[beta]1 integrin in epicardial development: initial migration and long-term attachment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Sengbusch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Pinco</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="873" to="882" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Rayburn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">O</forename><surname>Hynes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Development</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="549" to="560" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">PREVENTING OBESITY-INDUCED INSULIN RESISTANCE</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Tysabri raises alarm bells on drug class</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cormac</forename><surname>Sheridan</surname></persName>
		</author>
		<idno type="DOI">10.1038/nbt0405-397</idno>
		<idno type="PMID">15815649</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Biotechnology</title>
		<title level="j" type="abbrev">Nat Biotechnol</title>
		<idno type="ISSN">1087-0156</idno>
		<idno type="ISSNe">1546-1696</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="397" to="398" />
			<date type="published" when="2005-04" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Third Tysabri adverse case hits drug class</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cormac</forename><surname>Sheridan</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrd1743</idno>
		<idno type="PMID">15902765</idno>
		<idno type="ark">ark:/67375/GT4-H1QQCMB7-H</idno>
		<idno type="istexId">A3F472F2340E74F9F1200ABB50C675961DDAC42A</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Drug Discovery</title>
		<title level="j" type="abbrev">Nat Rev Drug Discov</title>
		<idno type="ISSN">1474-1776</idno>
		<idno type="ISSNe">1474-1784</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="357" to="358" />
			<date type="published" when="2005-05" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">New approaches to blockade of α4-integrins, proven therapeutic targets in chronic inflammation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christiane</forename><surname>Kummer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">H</forename><surname>Ginsberg</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bcp.2006.06.014</idno>
		<idno type="PMID">16870156</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical Pharmacology</title>
		<title level="j" type="abbrev">Biochemical Pharmacology</title>
		<idno type="ISSN">0006-2952</idno>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1460" to="1468" />
			<date type="published" when="2006-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Binding of paxillin to α4 integrins modifies integrin-dependent biological responses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shouchun</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sheila</forename><forename type="middle">M</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Darren</forename><forename type="middle">G</forename><surname>Woodside</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">M</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">B</forename><surname>Kiosses</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Pfaff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">H</forename><surname>Ginsberg</surname></persName>
		</author>
		<idno type="DOI">10.1038/45264</idno>
		<idno type="PMID">10604475</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">402</biblScope>
			<biblScope unit="issue">6762</biblScope>
			<biblScope unit="page" from="676" to="681" />
			<date type="published" when="1999-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">α4β1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the α4-cytoplasmic domain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronen</forename><surname>Alon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sara</forename><forename type="middle">W</forename><surname>Feigelson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eugenia</forename><surname>Manevich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">M</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Julia</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Darryl</forename><forename type="middle">R</forename><surname>Overby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eitan</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Valentin</forename><surname>Grabovsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vera</forename><surname>Shinder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Benjamin</forename><forename type="middle">D</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maya</forename><surname>Sokolovsky-Eisenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donald</forename><forename type="middle">E</forename><surname>Ingber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Benoit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">H</forename><surname>Ginsberg</surname></persName>
		</author>
		<idno type="DOI">10.1083/jcb.200503155</idno>
		<idno type="PMID">16365170</idno>
		<idno type="PMCID">PMC2171310</idno>
		<ptr type="open-access" target="http://jcb.rupress.org/content/171/6/1073.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Cell Biology</title>
		<title level="j" type="abbrev">J Cell Biol</title>
		<idno type="ISSN">0021-9525</idno>
		<idno type="ISSNe">1540-8140</idno>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1073" to="1084" />
			<date type="published" when="2005-12-19" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Paxillin Binding to the 4 Integrin Subunit Stimulates LFA-1 (Integrin L 2)-Dependent T Cell Migration by Augmenting the Activation of Focal Adhesion Kinase/Proline-Rich Tyrosine Kinase-2</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Woodside</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">D</forename><surname>Schlaepfer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Ginsberg</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.170.12.5912</idno>
		<idno type="PMID">12794117</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/170/12/5912.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="5912" to="5918" />
			<date type="published" when="2003-06-15" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Blocking the 4 integrin paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Feral</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Silverman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kaushansky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Ginsberg</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci26091</idno>
		<idno type="PMID">16470243</idno>
		<idno type="PMCID">PMC1361348</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/26091/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">Journal of Clinical Investigation</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="715" to="723" />
			<date type="published" when="2006-03-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisa</forename><forename type="middle">A</forename><surname>Lesniewski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sarah</forename><forename type="middle">E</forename><surname>Hosch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaap</forename><forename type="middle">G</forename><surname>Neels</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carl</forename><surname>De Luca</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mohammad</forename><surname>Pashmforoush</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carey</forename><forename type="middle">N</forename><surname>Lumeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shian-Huey</forename><surname>Chiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miriam</forename><surname>Scadeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><forename type="middle">R</forename><surname>Saltiel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jerrold</forename><forename type="middle">M</forename><surname>Olefsky</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm1550</idno>
		<idno type="PMID">17351624</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<title level="j" type="abbrev">Nat Med</title>
		<idno type="ISSN">1078-8956</idno>
		<idno type="ISSNe">1546-170X</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="455" to="462" />
			<date type="published" when="2007-03-11" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Inhibition of Th1- and Enhancement of Th2-Initiating Cytokines and Chemokines in Trichosanthin- Treated Macrophages</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weifeng</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wanqiu</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gang</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yongyong</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ming</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bing</forename><surname>Sun</surname></persName>
		</author>
		<idno type="DOI">10.1006/bbrc.2001.4940</idno>
		<idno type="PMID">11374886</idno>
		<idno type="PII">S0006-291X(01)94940-X</idno>
		<idno type="ark">ark:/67375/6H6-RMVWF0V2-9</idno>
		<idno type="istexId">ADB2C910A27D51D24EC48F0718400D95BDB9C997</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical and Biophysical Research Communications</title>
		<title level="j" type="abbrev">Biochemical and Biophysical Research Communications</title>
		<idno type="ISSN">0006-291X</idno>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="168" to="172" />
			<date type="published" when="2001-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">D</forename><surname>Purves</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf01062525</idno>
		<idno type="PMID">1522479</idno>
		<idno type="ark">ark:/67375/1BB-5Z9G59F7-L</idno>
		<idno type="istexId">0082AEB7095659093FB984D962A2DD3AC5BA4541</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Pharmacokinetics and Biopharmaceutics</title>
		<title level="j" type="abbrev">Journal of Pharmacokinetics and Biopharmaceutics</title>
		<idno type="ISSN">0090-466X</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="211" to="226" />
			<date type="published" when="1992-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Pharmacokinet Biopharm</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="211" to="226" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Brüning</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Winnay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Cheatham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">R</forename><surname>Kahn</surname></persName>
		</author>
		<idno type="DOI">10.1128/mcb.17.3.1513</idno>
		<idno type="PMID">9032279</idno>
		<idno type="PMCID">PMC231877</idno>
		<ptr type="open-access" target="http://mcb.asm.org/content/17/3/1513.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<title level="j" type="abbrev">Mol. Cell. Biol.</title>
		<idno type="ISSN">0270-7306</idno>
		<idno type="ISSNe">1098-5549</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1513" to="1521" />
			<date type="published" when="1997-03" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The pathophysiologic role of alpha 4 integrins in vivo.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">R</forename><surname>Lobb</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Hemler</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci117519</idno>
		<idno type="PMID">7525645</idno>
		<idno type="PMCID">PMC294562</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/117519/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1722" to="1728" />
			<date type="published" when="1994-11-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">α4Integrins as Therapeutic Targets in Autoimmune Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ulrich</forename><forename type="middle">H</forename><surname>Von Andrian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Britta</forename><surname>Engelhardt</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejme020157</idno>
		<idno type="PMID">12510047</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="68" to="72" />
			<date type="published" when="2003-01-02" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Obesity is associated with macrophage accumulation in adipose tissue</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stuart</forename><forename type="middle">P</forename><surname>Weisberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Manisha</forename><surname>Desai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Rosenbaum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rudolph</forename><forename type="middle">L</forename><surname>Leibel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><forename type="middle">W</forename><surname>Ferrante</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci19246</idno>
		<idno type="PMID">14679176</idno>
		<idno type="PMCID">PMC296995</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/19246/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1796" to="1808" />
			<date type="published" when="2003-12-15" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">VLA Proteins In The Integrin Family: Structures, Functions, And Their Role On Leukocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Hemler</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.immunol.8.1.365</idno>
	</analytic>
	<monogr>
		<title level="j">Annual Review of Immunology</title>
		<idno type="ISSN">0732-0582</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="365" to="400" />
			<date type="published" when="1990-01-01" />
			<publisher>Annual Reviews</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Role of macrophage tissue infiltration in metabolic diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><surname>Bouloumié</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cyrile</forename><forename type="middle">Anne</forename><surname>Curat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Coralie</forename><surname>Sengenès</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karine</forename><surname>Lolmède</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexandra</forename><surname>Miranville</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rudi</forename><surname>Busse</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.mco.0000172571.41149.52</idno>
		<idno type="PMID">15930956</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Clinical Nutrition and Metabolic Care</title>
		<title level="j" type="abbrev">Current Opinion in Clinical Nutrition and Metabolic Care</title>
		<idno type="ISSN">1363-1950</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="347" to="354" />
			<date type="published" when="2005-07" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chia-Lin</forename><surname>Tsou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wendy</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yue</forename><surname>Si</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sarah</forename><surname>Slaymaker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ara</forename><forename type="middle">M</forename><surname>Aslanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stuart</forename><forename type="middle">P</forename><surname>Weisberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><surname>Mack</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Israel</forename><forename type="middle">F</forename><surname>Charo</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci29919</idno>
		<idno type="PMID">17364026</idno>
		<idno type="PMCID">PMC1810572</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/29919/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="902" to="909" />
			<date type="published" when="2007-04-02" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">The Ly-6Chigh Monocyte Subpopulation Transports Listeria monocytogenes into the Brain during Systemic Infection of Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Drevets</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Dillon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Schawang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Van Rooijen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ehrchen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Sunderkotter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J M</forename><surname>Leenen</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.172.7.4418</idno>
		<idno type="PMID">15034057</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/172/7/4418.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="4418" to="4424" />
			<date type="published" when="2004-03-19" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Rapid recruitment of inflammatory monocytes is independent of neutrophil migration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Henderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Hobbs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Mathies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Hogg</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2002-10-3228</idno>
		<idno type="PMID">12623845</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/2efb/c6e50c166ec61d192792602b2ccabd94380c.pdf" />
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<title level="j" type="abbrev">Blood</title>
		<idno type="ISSN">0006-4971</idno>
		<idno type="ISSNe">1528-0020</idno>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="328" to="335" />
			<date type="published" when="2003-03-20" />
			<publisher>American Society of Hematology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Sunderkotter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Nikolic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Dillon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Van Rooijen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Stehling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Drevets</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J M</forename><surname>Leenen</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.172.7.4410</idno>
		<idno type="PMID">15034056</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/172/7/4410.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="4410" to="4417" />
			<date type="published" when="2004-03-19" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Tacke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Florent</forename><surname>Ginhoux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claudia</forename><surname>Jakubzick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nico</forename><surname>Van Rooijen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miriam</forename><surname>Merad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gwendalyn</forename><forename type="middle">J</forename><surname>Randolph</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20052119</idno>
		<idno type="PMID">16492803</idno>
		<idno type="PMCID">PMC2118235</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/203/3/583.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">203</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="583" to="597" />
			<date type="published" when="2006-02-21" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Cancello</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Tordjman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Poitou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Guilhem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Bouillot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Hugol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Coussieu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Basdevant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Hen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Bedossa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Guerre-Millo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Clement</surname></persName>
		</author>
		<idno type="DOI">10.2337/db06-0133</idno>
		<idno type="PMID">16731817</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/55/6/1554.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1554" to="1561" />
			<date type="published" when="2006-05-26" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Inflammatory Process in Type 2 Diabetes: The Role of Cytokines</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Alexandraki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Piperi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Kalofoutis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Alaveras</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Kalofoutis</surname></persName>
		</author>
		<idno type="DOI">10.1196/annals.1372.039</idno>
		<idno type="PMID">17151295</idno>
		<idno type="ark">ark:/67375/WNG-X93GRPSP-L</idno>
		<idno type="istexId">83597B9D9716F0C9D7E5589CAA02F5B1ED530E67</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of the New York Academy of Sciences</title>
		<title level="j" type="abbrev">Annals of the New York Academy of Sciences</title>
		<idno type="ISSN">0077-8923</idno>
		<imprint>
			<biblScope unit="volume">1084</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="89" to="117" />
			<date type="published" when="2006-11-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Diet Induction of Monocyte Chemoattractant Protein-1 and its Impact on Obesity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Airu</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sheena</forename><surname>Mumick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chunsheng</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Lamb</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongyue</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Drew</forename><surname>Weingarth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Mudgett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Howard</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">J</forename><surname>Macneil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><forename type="middle">L</forename><surname>Reitman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Su</forename><surname>Qian</surname></persName>
		</author>
		<idno type="DOI">10.1038/oby.2005.159</idno>
		<idno type="PMID">16129712</idno>
	</analytic>
	<monogr>
		<title level="j">Obesity Research</title>
		<idno type="ISSN">1071-7323</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1311" to="1320" />
			<date type="published" when="2005-08" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Matsushima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">G</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">C</forename><surname>Dubois</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Oppenheim</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.169.4.1485</idno>
		<idno type="PMID">2926331</idno>
		<idno type="PMCID">PMC2189236</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2189236?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">Journal of Experimental Medicine</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1485" to="1490" />
			<date type="published" when="1989-04-01" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Human monocyte chemoattractant protein-1 (MCP-1) Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Teizo</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoya</forename><surname>Yuhki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><forename type="middle">K</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ettore</forename><surname>Appella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">I</forename><surname>Lerman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Edward</forename><forename type="middle">J</forename><surname>Leonard</surname></persName>
		</author>
		<idno type="DOI">10.1016/0014-5793(89)80590-3</idno>
		<idno type="PMID">2465924</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Letters</title>
		<idno type="ISSN">0014-5793</idno>
		<imprint>
			<biblScope unit="volume">244</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="487" to="493" />
			<date type="published" when="1989-02-27" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">α4 Integrins Regulate the Proliferation/Differentiation Balance of Multilineage Hematopoietic Progenitors In Vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alicia</forename><forename type="middle">G</forename><surname>Arroyo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joy</forename><forename type="middle">T</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helen</forename><surname>Rayburn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">O</forename><surname>Hynes</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1074-7613(00)80131-4</idno>
		<idno type="PMID">10591181</idno>
		<idno type="PII">S1074-7613(00)80131-4</idno>
		<idno type="ark">ark:/67375/6H6-9LTRW7V9-V</idno>
		<idno type="istexId">8BC97F15A8F488C64A9B9B97D5BB15566B476987</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<title level="j" type="abbrev">Immunity</title>
		<idno type="ISSN">1074-7613</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="555" to="566" />
			<date type="published" when="1999-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Deletion of 4 Integrins from Adult Hematopoietic Cells Reveals Roles in Homeostasis, Regeneration, and Homing</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">V</forename><surname>Priestley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Papayannopoulou</surname></persName>
		</author>
		<idno type="DOI">10.1128/mcb.23.24.9349-9360.2003</idno>
		<idno type="PMID">14645544</idno>
		<idno type="PMCID">PMC309677</idno>
		<ptr type="open-access" target="https://mcb.asm.org/content/23/24/9349.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Molecular and Cellular Biology</title>
		<title level="j" type="abbrev">Molecular and Cellular Biology</title>
		<idno type="ISSN">0270-7306</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="9349" to="9360" />
			<date type="published" when="2003-11-26" />
			<publisher>American Society for Microbiology</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Inflammation and the etiology of type 2 diabetes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Åke</forename><surname>Sjöholm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><surname>Nyström</surname></persName>
		</author>
		<idno type="DOI">10.1002/dmrr.568</idno>
		<idno type="PMID">15991254</idno>
		<idno type="ark">ark:/67375/WNG-KVP9WZ6K-W</idno>
		<idno type="istexId">A7773755F537E99179110126A7FDAC9436CED4D8</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes/Metabolism Research and Reviews</title>
		<title level="j" type="abbrev">Diabetes Metab. Res. Rev.</title>
		<idno type="ISSN">1520-7552</idno>
		<idno type="ISSNe">1520-7560</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="4" to="10" />
			<date type="published" when="2005" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Inhibition of 4 Integrin and ICAM-1 Markedly Attenuate Macrophage Homing to Atherosclerotic Plaques in ApoE-Deficient Mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Thiagarajan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Willerson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T H</forename><surname>Yeh</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.97.1.75</idno>
		<idno type="PMID">9443434</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.97.1.75" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="75" to="81" />
			<date type="published" when="1998-01-13" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Obesity induces a phenotypic switch in adipose tissue macrophage polarization</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carey</forename><forename type="middle">N</forename><surname>Lumeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><forename type="middle">L</forename><surname>Bodzin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><forename type="middle">R</forename><surname>Saltiel</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci29881</idno>
		<idno type="PMID">17200717</idno>
		<idno type="PMCID">PMC1716210</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/29881/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="175" to="184" />
			<date type="published" when="2007-01-02" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">T Audrey</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Svetlana</forename><surname>Favelyukis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anh-Khoi</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Donna</forename><surname>Reichart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><surname>Jenn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ru</forename><surname>Liu-Bryan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christopher</forename><forename type="middle">K</forename><surname>Glass</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jaap</forename><forename type="middle">G</forename><surname>Neels</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jerrold</forename><forename type="middle">M</forename><surname>Olefsky</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m706762200</idno>
		<idno type="PMID">17916553</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/282/48/35279.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="issue">48</biblScope>
			<biblScope unit="page" from="35279" to="35292" />
			<date type="published" when="2007-10-04" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Monocyte and macrophage heterogeneity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Siamon</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philip</forename><forename type="middle">R</forename><surname>Taylor</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri1733</idno>
		<idno type="PMID">16322748</idno>
		<idno type="ark">ark:/67375/GT4-XDF2BBX8-N</idno>
		<idno type="istexId">90E2EF91CAAF4BE5C10E5D41167480B0990E7A0D</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Immunology</title>
		<title level="j" type="abbrev">Nat Rev Immunol</title>
		<idno type="ISSN">1474-1733</idno>
		<idno type="ISSNe">1474-1741</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="953" to="964" />
			<date type="published" when="2005-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">CCR2 modulates inflammatory and metabolic effects of high-fat feeding</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">P</forename><surname>Weisberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lemieux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Slaymaker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Vaddi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charo</forename><forename type="middle">I</forename><surname>Leibel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename></persName>
		</author>
		<idno type="DOI">10.1172/jci24335c1</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/24335C1/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">Journal of Clinical Investigation</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1457" to="1457" />
			<date type="published" when="2006-05-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Cardiovascular metabolic syndrome ? an interplay of, obesity, inflammation, diabetes and coronary heart disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Rana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Nieuwdorp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Jukema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J P</forename><surname>Kastelein</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1463-1326.2006.00594.x</idno>
		<idno type="PMID">17391148</idno>
		<idno type="ark">ark:/67375/WNG-KQ1NQ9N1-L</idno>
		<idno type="istexId">02A6F2EC5CD23406981A2A42F8BEEC0E8AAEA5F0</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes, Obesity and Metabolism</title>
		<title level="j" type="abbrev">Diabetes Obes Metab</title>
		<idno type="ISSN">1462-8902</idno>
		<idno type="ISSNe">1463-1326</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="218" to="232" />
			<date type="published" when="2007-05" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
